# OrbiMed Asia: portfolio, investments and team > OrbiMed Asia is a private equity. 3 investments on record, latest Mar 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/orbimed-asia (Millionrounds; every figure on the page links to its filing or article) [Investor](https://millionrounds.com/investors) # OrbiMed Asia Filed with the SEC to raise a fund in Oct 2026, closing $1,046M. Last cheque observed Mar 2019. Quiet New fund $1.0B, Oct 2026 Private equity Series A Series C Cheques on record **0%** of best year **0** **cheques in 12 months**, 3 on record Since the last cheque **2786** days **00** hrs **00** min **00** sec Median round **$19M** Rounds led **1 of 3** Sole investor **1 rounds** Pitch OrbiMed Asia ## OrbiMed Asia highlights - 01 3 rounds on record - 02 Mostly Series A and Series C: 100% of its rounds - 03 Sole investor in 1 rounds, median $9.8M ## What they do - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **3 appearances** - **2019** 1 round - **Mar** **[InventisBio](https://millionrounds.com/company/inventisbio)** Series C · CN · FinSMEs **$70M** With 4 others - **2018** 1 round - **Jun** **[Laekna](https://millionrounds.com/company/laekna)** Series A · CN · Biocentury **$19M** *Led* - **2016** 1 round - **Aug** **[CBT Pharmaceuticals](https://millionrounds.com/company/cbt-pharmaceuticals)** Series A · US · FinSMEs **$9.8M** Sole investor An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **8 named** CL **Carl L. Gordon** Director of the GPLTD i Filing they signed DG **David G. Wang** Director of the GPLTD i Filing they signed JG **Jonathan G. Wang** Director of the GPLTD i Filing they signed JT **Jonathan T. Silverstein** Director of the GPLTD i Filing they signed SD **Samuel D. Isaly** Director of the GPLTD i Filing they signed SC **Sunny Carter Sharma** Director of the GPLTD i Filing they signed SH **Sven H. Borho** Director of the GPLTD i Filing they signed WC **W. Carter Neild** Director of the GPLTD i Filing they signed We also hold **4** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. New fund on file **$1.0B** raised in Oct 2026 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series A Series C Median round joined **$19M** the round, not its cheque Alone, median **$9.8M** Led 1 of 3 rounds **33%** - **Sole investor:** 1 rounds - **Last cheque:** Mar 2019 Rounds by stage said on their site - Series A *2* - Series C *1* Cheques by year Led Joined 2016 2019 **Pitching OrbiMed Asia?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Recently backed The latest companies OrbiMed Asia put money into. [**InventisBio** $70M · Mar 2019](https://millionrounds.com/company/inventisbio) ## Quick answers about OrbiMed Asia ### What does OrbiMed Asia invest in? OrbiMed Asia invests most often at Series A and Series C (100% of the rounds on record). ### How active is OrbiMed Asia? 3 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Mar 2019. ### What has OrbiMed Asia invested in recently? Its most recent investments on record: InventisBio (Series C, Mar 2019), Laekna (Series A, Jun 2018) and CBT Pharmaceuticals (Series A, Aug 2016). ### How big are OrbiMed Asia's cheques? The median round it joins is $19M. ### Is OrbiMed Asia investing now? No investments in the last 12 months; the latest was in Mar 2019. ### What kind of investor is OrbiMed Asia? OrbiMed Asia is a private equity firm. ### Has OrbiMed Asia raised a new fund? Its latest fund filing with the SEC was in Oct 2026, reporting $1.0B raised. ### Where does this information on OrbiMed Asia come from? From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=orbimed-asia) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=orbimed-asia)